Literature DB >> 30694340

Is an elevated burden of antiarrhythmic drug (AAD) side-effects the unavoidable price to be traded for a durable suppression of AF relapses in ablated patients? The weaknesses and risks of the AAD suppression algorithm used by current models of AF secondary prevention after catheter ablation.

Renato De Vecchis1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30694340     DOI: 10.1007/s00228-019-02638-9

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  18 in total

1.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

Review 2.  Drug-induced long QT and torsade de pointes: recent advances.

Authors:  Prince J Kannankeril; Dan M Roden
Journal:  Curr Opin Cardiol       Date:  2007-01       Impact factor: 2.161

3.  Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study).

Authors:  Giuseppe Stabile; Emanuele Bertaglia; Gaetano Senatore; Antonio De Simone; Franco Zoppo; Giovanni Donnici; Pietro Turco; Pietro Pascotto; Massimo Fazzari; Dino Franco Vitale
Journal:  Eur Heart J       Date:  2005-10-07       Impact factor: 29.983

4.  A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.

Authors:  Carlo Pappone; Giuseppe Augello; Simone Sala; Filippo Gugliotta; Gabriele Vicedomini; Simone Gulletta; Gabriele Paglino; Patrizio Mazzone; Nicoleta Sora; Isabelle Greiss; Andreina Santagostino; Laura LiVolsi; Nicola Pappone; Andrea Radinovic; Francesco Manguso; Vincenzo Santinelli
Journal:  J Am Coll Cardiol       Date:  2006-10-16       Impact factor: 24.094

5.  Rhythm control versus rate control for atrial fibrillation and heart failure.

Authors:  Denis Roy; Mario Talajic; Stanley Nattel; D George Wyse; Paul Dorian; Kerry L Lee; Martial G Bourassa; J Malcolm O Arnold; Alfred E Buxton; A John Camm; Stuart J Connolly; Marc Dubuc; Anique Ducharme; Peter G Guerra; Stefan H Hohnloser; Jean Lambert; Jean-Yves Le Heuzey; Gilles O'Hara; Ole Dyg Pedersen; Jean-Lucien Rouleau; Bramah N Singh; Lynne Warner Stevenson; William G Stevenson; Bernard Thibault; Albert L Waldo
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

Review 6.  Curative ablation for atrial fibrillation: a systematic review.

Authors:  Knut Gjesdal; Gunn E Vist; Einar Bugge; Ole Rossvoll; Marit Johansen; Inger Norderhaug; Ole-J Ohm
Journal:  Scand Cardiovasc J       Date:  2008-02       Impact factor: 1.589

7.  Atrial fibrillation progression and management: a 5-year prospective follow-up study.

Authors:  Carlo Pappone; Andrea Radinovic; Francesco Manguso; Gabriele Vicedomini; Giuseppe Ciconte; Stefania Sacchi; Patrizio Mazzone; Gabriele Paglino; Simone Gulletta; Simone Sala; Vincenzo Santinelli
Journal:  Heart Rhythm       Date:  2008-08-17       Impact factor: 6.343

8.  Protracted CRP elevation after atrial fibrillation ablation.

Authors:  James M McCabe; Lisa M Smith; Zian H Tseng; Nitish Badhwar; Byron K Lee; Randall J Lee; Melvin M Scheinman; Jeffrey E Olgin; Gregory M Marcus
Journal:  Pacing Clin Electrophysiol       Date:  2008-09       Impact factor: 1.976

Review 9.  A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation.

Authors:  Girish M Nair; Pablo B Nery; Syamkumar Diwakaramenon; Jeffrey S Healey; Stuart J Connolly; Carlos A Morillo
Journal:  J Cardiovasc Electrophysiol       Date:  2008-09-03

10.  Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study.

Authors:  Pierre Jaïs; Bruno Cauchemez; Laurent Macle; Emile Daoud; Paul Khairy; Rajesh Subbiah; Mélèze Hocini; Fabrice Extramiana; Fréderic Sacher; Pierre Bordachar; George Klein; Rukshen Weerasooriya; Jacques Clémenty; Michel Haïssaguerre
Journal:  Circulation       Date:  2008-11-24       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.